Sharon Benzeno, PhD is the Chief Business Development Officer and leads the Drug Discovery group of Adaptive Biotechnologies. Prior to joining Adaptive in 2014, Sharon was Senior Director at Elsevier Inc., a healthcare informatics company. Prior to Elsevier, Sharon co-led the oncology business unit at Capgemini SE, a consulting and technology services company. Prior to Capgemini, Sharon served in a variety of management roles at AstraZeneca.